
Augustine Kunle Obisesan
Examiner (ID: 8490, Phone: (571)272-2020 , Office: P/2156 )
| Most Active Art Unit | 2156 |
| Art Unit(s) | 2169, 2156 |
| Total Applications | 825 |
| Issued Applications | 506 |
| Pending Applications | 72 |
| Abandoned Applications | 275 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16726576
[patent_doc_number] => 20210093723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => LIQUID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/114104
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114104 | Liquid compositions | Dec 6, 2020 | Issued |
Array
(
[id] => 16883681
[patent_doc_number] => 20210169876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => TREATING LIVER DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/114379
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114379 | Treating liver disease by selectively eliminating senescent cells | Dec 6, 2020 | Issued |
Array
(
[id] => 16883680
[patent_doc_number] => 20210169875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => TREATING CARDIOVASCULAR DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/114376
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114376 | Treating cardiovascular disease by selectively eliminating senescent cells | Dec 6, 2020 | Issued |
Array
(
[id] => 17895372
[patent_doc_number] => 20220305034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/287661
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287661 | N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors | Dec 2, 2020 | Issued |
Array
(
[id] => 18716475
[patent_doc_number] => 11793796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Inhibition of crystal growth of roflumilast
[patent_app_type] => utility
[patent_app_number] => 17/102056
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6031
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102056 | Inhibition of crystal growth of roflumilast | Nov 22, 2020 | Issued |
Array
(
[id] => 17043774
[patent_doc_number] => 11096933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Method of treating disorders associated with chronic inflammation
[patent_app_type] => utility
[patent_app_number] => 17/084012
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 23228
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17084012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/084012 | Method of treating disorders associated with chronic inflammation | Oct 28, 2020 | Issued |
Array
(
[id] => 19225409
[patent_doc_number] => 12005039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Methods and compositions relating to lipokines for treating metabolic disorders
[patent_app_type] => utility
[patent_app_number] => 17/080528
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 59
[patent_no_of_words] => 18246
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080528 | Methods and compositions relating to lipokines for treating metabolic disorders | Oct 25, 2020 | Issued |
Array
(
[id] => 16822604
[patent_doc_number] => 20210137897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => TOPICAL mTOR INHIBITORS FOR CUTANEOUS PROLIFERATIVE AND VASCULAR CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/076932
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076932 | TOPICAL mTOR INHIBITORS FOR CUTANEOUS PROLIFERATIVE AND VASCULAR CONDITIONS | Oct 21, 2020 | Abandoned |
Array
(
[id] => 16791613
[patent_doc_number] => 20210121430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => OMEGA-3 FATTY ACID SUPPLEMENTATION FOR USE IN TREATING DRY EYE
[patent_app_type] => utility
[patent_app_number] => 17/077463
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077463 | OMEGA-3 FATTY ACID SUPPLEMENTATION FOR USE IN TREATING DRY EYE | Oct 21, 2020 | Abandoned |
Array
(
[id] => 16619933
[patent_doc_number] => 20210038586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => VACUOLE-INDUCING COMPOUNDS, METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/075065
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075065
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075065 | Vacuole-inducing compounds, methods of making and using the same | Oct 19, 2020 | Issued |
Array
(
[id] => 17052249
[patent_doc_number] => 20210261683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/064981
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064981
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064981 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES | Oct 6, 2020 | Abandoned |
Array
(
[id] => 16619965
[patent_doc_number] => 20210038618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ALZHEIMER'S DISEASE USING PHYTIC ACID AND PHYTATE TO REDUCE AMYLOID BETA PLAQUE AND TAU PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/064536
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064536 | Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein | Oct 5, 2020 | Issued |
Array
(
[id] => 16581338
[patent_doc_number] => 20210015740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => TOPICAL CANNABINOID COMPOSITIONS, DELIVERY SYSTEMS, AND USES FOR PAIN RELIEF
[patent_app_type] => utility
[patent_app_number] => 17/036905
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/036905 | TOPICAL CANNABINOID COMPOSITIONS, DELIVERY SYSTEMS, AND USES FOR PAIN RELIEF | Sep 28, 2020 | Abandoned |
Array
(
[id] => 20142717
[patent_doc_number] => 12377032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Compound for use in protecting skin
[patent_app_type] => utility
[patent_app_number] => 17/032616
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 1860
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032616 | Compound for use in protecting skin | Sep 24, 2020 | Issued |
Array
(
[id] => 17020838
[patent_doc_number] => 20210244709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/020196
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020196 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | Sep 13, 2020 | Abandoned |
Array
(
[id] => 16539321
[patent_doc_number] => 20200405734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => HOMOGENEOUS OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/018040
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018040 | Homogeneous ophthalmic composition | Sep 10, 2020 | Issued |
Array
(
[id] => 18666466
[patent_doc_number] => 11773344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Terpene-based compositions, processes, methodologies for creation and products thereby
[patent_app_type] => utility
[patent_app_number] => 17/002666
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 52954
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/002666 | Terpene-based compositions, processes, methodologies for creation and products thereby | Aug 24, 2020 | Issued |
Array
(
[id] => 18932487
[patent_doc_number] => 11884895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Terpene-based compositions, methodologies for creation and products thereby
[patent_app_type] => utility
[patent_app_number] => 17/002606
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 52931
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/002606 | Terpene-based compositions, methodologies for creation and products thereby | Aug 24, 2020 | Issued |
Array
(
[id] => 19777395
[patent_doc_number] => 12226415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Methods and compositions for the treatment of hair loss
[patent_app_type] => utility
[patent_app_number] => 17/632973
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24001
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632973 | Methods and compositions for the treatment of hair loss | Aug 2, 2020 | Issued |
Array
(
[id] => 16452454
[patent_doc_number] => 20200361880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => 1,2,4-Oxadiazole and Thiadiazole Compounds as Immunomodulators
[patent_app_type] => utility
[patent_app_number] => 16/945854
[patent_app_country] => US
[patent_app_date] => 2020-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16945854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/945854 | 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators | Jul 31, 2020 | Issued |